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ABSTRACT
Adequate development of uterine receptivity is crucial for establishment of pregnancy. Expression of uterine receptivity 
molecules i.e. αvβ3 integrin, E-cadherin and mucin-1 could be affected by testosterone. The objective of this study was 
to investigate effect of testosterone on expression of these molecules during early pregnancy. 30 ovariectomised female 
Sprague-Dawley rats were divided into 5 groups that consisted of vehicle control, rats received eight days sex-steroid 
replacement regime (intended to mimic the hormonal changes in early pregnancy) and three groups of rats given 
testosterone (1 mg/kg/day) subcutaneously with or without flutamide or finasteride between day 6 and 8 representing the 
period of uterine receptivity. At the end of the treatment, rats were sacrificed and uteri were removed. Expression and 
distribution of αvβ3 integrin, E-cadherin and mucin-1 were examined by immunoflourescence and levels of messenger 
RNA (mRNAs) were evaluated by real-time PCR. Expression of αvβ3 integrin, E-cadherin and mucin-1 in the uteri of 
rats receiving sex-steroid replacement regime increased significantly as compared to control (p<0.05). In these rats, 
concomitant administration of testosterone between day 6 and 8 resulted in expression of αvβ3 integrin, E-cadherin 
and mucin-1 to decrease significantly (p<0.05) as compared to rats receiving sex-steroid replacement regime without 
testosterone treatment. Moreover, the testosterone effects were not antagonized by either flutamide or finasteride. As 
a result, reduced expression of uterine receptivity molecules by testosterone might interfere with early pregnancy 
establishment, therefore could adversely affect the female fertility. 
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ABSTRAK
Perkembangan yang mencukupi bagi reseptif rahim adalah penting untuk membolehkan kehamilan berlaku. Pengekspresan 
molekul reseptif rahim seperti αvβ3 integrin, E-cadherin dan mucin-1 boleh dipengaruhi oleh testosteron. Objektif kajian 
ini adalah untuk mengkaji kesan testosteron terhadap pengekspresan molekul ini semasa peringkat awal kehamilan. 30 
ekor tikus Sprague-Dawley yang telah diovariektomi dibahagikan kepada 5 kumpulan terdiri daripada kumpulan kawalan, 
kumpulan tikus yang menerima regim penggantian steroid seks selama lapan hari (bertujuan untuk meniru perubahan 
hormon semasa peringkat awal kehamilan) dan tiga kumpulan tikus yang diberikan rawatan testosteron  (1 mg/kg/hari) 
secara subkulitan dengan atau tanpa kehadiran flutamide atau finasteride antara hari ke-6 hingga ke-8 rawatan yang 
mewakili tempoh reseptif rahim. Di akhir rawatan, tikus telah dikorbankan dan uteri dikeluarkan. Pengekspresan dan 
taburan αvβ3 integrin, E-cadherin dan mucin-1 ditentukan dengan menggunakan immunoflourescence dan paras mRNA 
ditentukan dengan menggunakan Real-time PCR. Pengekspresan αvβ3 integrin, E-cadherin dan mucin-1 dalam uteri 
tikus yang menerima regim penggantian steroid seks didapati meningkat secara signifikan berbanding kawalan (p<0.05). 
Pada tikus ini, pemberian bersama testosteron antara hari ke-6 hingga hari ke-8 telah menyebabkan pengekspresan 
αvβ3 integrin, E-cadherin dan mucin-1 menurun dengan signifikan (p<0.05) berbanding kumpulan yang menerima regim 
penggantian steroid seks tanpa rawatan testosteron. Selain itu, kesan testosteron ini tidak ditentang oleh flutamide atau 
finasteride. Kesimpulannya, penurunan pengekspresan molekul reseptif rahim oleh testosteron mungkin mengganggu 
perkembangan awal kehamilan dan seterusnya boleh menjejaskan kesuburan wanita.
Kata kunci: αvβ3 integrin; E-cadherin; mucin-1; reseptif rahim; testosteron 
INTRODUCTION
Uterine receptivity is a period where complex signals exist 
between the embryo and the maternal endometrium (Simon 
et al. 2000). The events that occur during uterine receptivity 
are precisely coordinated by the ovarian hormones, namely 
oestrogen and progesterone (Paulson 2011). During the 
uterine receptivity period, several molecules including 
integrins, E-cadherin and mucin-1 are expressed in the 
endometrium (Aplin 2000). Integrins are involved in the 
interactions between cell to cell and cell to matrix (Lessey 
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2003). It consists of two different, non-covalently linked 
subunits, i.e. α and β. Integrins have been identified as one 
of the markers of endometrial receptivity and can be found 
in the epithelium and stroma (Lessey et al. 1994). There are 
three integrins isoforms: α1β1, α4β1 and αvβ3 (Thomas 
et al. 2002). Amongst these, αvβ3 integrin can interact 
with the trophoblast during the uterine receptivity period 
(Apparao et al. 2001). αvβ3 integrin has been proposed 
to mediate attachment of the embryo to the receptive 
endometrium (Lessey 2003). 
 Cadherins are group of glycoproteins which play a role 
in calcium-dependent cell-to-cell adhesion (Kowalski et al. 
2003; Nurismah et al. 2008). Cadherins can be divided into 
three types i.e. epithelial (E), placental (P) and neural (N) 
cadherins. E-cadherin is involved in embryo implantation 
(Achache & Revel 2006). It is a 120-kDa transmembrane 
protein that mediates epithelial cells adhesion (Yoshida-
Noro et al. 1984). E-cadherin is expressed at the apical 
membrane of the endometrial luminal epithelium and 
participates in trophoblast attachment. Expression of 
E-cadherin between the adjacent epithelial cells is altered 
during trophoblast invasion (Li et al. 2002). 
 Mucin-1, a high molecular weight glycosylated 
macromolecule (> 200 kDa) is known to play a role as 
anti-adhesive agent. The presence of mucin-1 can interfere 
with cellular adhesion via a steric hindrance phenomenon 
and thus, this can prevent the adhesion of the implanting 
blastocyst to the endometrium. Additionally, mucin-1 
can help to lubricate and protect the blastocyst from 
proteolysis and from microbial attacks (Brayman et al. 
2004). In the uterus, mucin-1 is found to be expressed at 
the apical surface of the luminal and glandular epithelia. 
Down-regulation of mucin-1 expression will remove the 
barrier between blastocyst and endometrium, thus allowing 
the blastocyst to attach to the endometrium (Carson et al. 
2000). High mucin-1 expression was reported during the 
peri-implantation period in humans (DeSouza et al. 1998). 
 Testosterone possesses strong androgenic effects 
which are important for both male and female (Mohamad 
et al. 2016). It has been reported to affect the reproductive 
processes in male and female. In female, the physiological 
testosterone level is much lower compared to male and 
the level rises immediately after ovulation (Davison et 
al. 2005; Nur Vaizura et al. 2018). In pathophysiological 
condition such as polycystic ovarian disease (PCO), plasma 
testosterone level is higher than normal (Apparao et al. 
2002; Shafiee et al. 2013). The high level of testosterone 
can cause infertility among premenopausal women as 
it can suppress ovulation (Johansson & Stener-Victorin 
2013; Mohamed-Hussein & Harun 2009) as well as 
decidualisation (Gonzalez et al. 2012). In addition, the high 
plasma testosterone level can also suppress the expression 
of genes that participate in uterine receptivity development 
(Yan et al. 2012). The effect of high plasma testosterone 
on expression of αvβ3 integrin, E-cadherin and mucin-1 
which play a role during implantation is however unknown. 
 Our previous study showed the high plasma level 
of testosterone in female could suppress pinopode 
development and expression of MECA-79 under the 
influence of progesterone (Mohd Mokhtar et al. 2014). In 
this study, we hypothesized that high plasma testosterone 
level in female could affect expression of αvβ3 integrin, 
E-cadherin and mucin-1 during the uterine receptivity 
period. These could potentially interfere with blastocyst 
attachment and ultimately embryo implantation. Increased 
knowledge on the mechanism underlying these effects can 
lead to strategies for correcting implantation failure.
MATERIALS AND METHODS
ANIMALS & HORMONAL TREATMENT
Three-month-old adult female Sprague-Dawley (SD) rats 
(n=30), weighing 225 ± 25 g were caged under standard 
conditions (lights on 06:00 to 18:00 h; room temperature 
24°C; 4 animals per cage). Animals were fed with rat 
chow diet (Harlan, Germany) and tap water ad libitum. 
All experimental procedures were approved by University 
of Malaya institutional ethics committee (2013-07-15/
FIS/R/NS). Oestrogen, testosterone, flutamide, finasteride 
and peanut oil were obtained from Sigma–Aldrich, 
USA. Bilateral ovariectomy was performed twenty-one 
days prior to steroid treatment to eliminate the effect of 
endogenous sex-steroids (Salleh et al. 2005). Drugs were 
dissolved in peanut oil prior to subcutaneous administration 
behind the neck scruff. 
 In this study, ovariectomised rats were treated with 
sex-steroid regime to mimic the hormonal changes in early 
pregnancy. The regime include injection of 1.0 μg/kg/day 
estrogen at day 1 and day 2, 1.0 μg/kg/day estrogen and 4 
mg/kg/day progesterone at day 3, no treatment at the 4th 
and 5th day, 16 mg/kg/day progesterone and 0.5 μg/kg/day 
estrogen between days 6 and 8 according to the established 
protocol by Kennedy (Kennedy 1986). Vehicle-treated 
animals which acted as control received 8 daily injections 
of peanut oil. 1 mg/kg/day testosterone, the dose regarded 
as supra-physiological in females (Dehghan et al. 2014) 
was given for three (3) days between days 6-8 that was 
considered as a period of uterine receptivity. Testosterone 
was given with flutamide (5 mg/kg/day) or finasteride (1 
mg/kg/day). Both inhibitors were administered 30 min 
prior to testosterone injection.
IMMUNOFLUORESCENCE (IF) FOR DETECTION                          
OF PROTEIN DISTRIBUTION
Uterine sections were blocked in 10% normal rabbit 
serum (sc-2338) (Santa Cruz, CA, USA) prior to incubation 
with rabbit polyclonal Integrin αv/β3 Antibody (Cat. No. 
251672) (Abbiotec, 7985 Dunbrook Rd., Ste A San Diego, 
CA 92126, USA), goat polyclonal IgG E-cadherin primary 
antibody (sc-31020) and goat polyclonal IgG mucin-1 
primary antibody (sc-6827) purchased from Santa Cruz, 
CA, USA. The antibodies were diluted at 1:100 in PBS with 
1.5% normal blocking serum at room temperature for 1 h. 
After three times rinsing with PBS, sections were incubated 
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with rabbit anti-goat IgG–fluorochrome-conjugated 
secondary antibody (sc-2777) (Santa Cruz, CA, USA) at a 
dilution of 1:250 in PBS with 1.5% normal blocking serum 
at room temperature for 45 min. The slides were rinsed 
three times with PBS and were mounted with Ultracruz 
Mounting Medium (Santa Cruz, CA, USA). Counterstaining 
with DAPI was done to visualize the nuclei. All images were 
viewed under Nikon Eclipse 80i camera that was attached 
to a light microscope. Negative controls were performed 
by incubating the sections with non-immune IgG. 
REAL-TIME PCR (QPCR) FOR QUANTIFICATION OF 
MESSENGER RNA (MRNA)
Whole uterine tissues were kept in RNALater solution 
(Ambion, Carlsbad, CA, USA), prior to RNA extraction. 
RNA was extracted by using RNeasy Plus Mini Kit 
(Qiagen, Hilden, Germany) and its concentration was 
assessed by 260/280 UV absorption ratios (Gene Quant 
1300, Cambridge, UK). Gene expression was evaluated by 
using two steps real-time PCR and the cDNA was reversely 
transcribed to RNA by using high capacity RNA-to-cDNA Kit 
(Applied Biosystems, Foster City, CA, USA). Amplifications 
on samples with no reverse transcriptase (-RT) acts as 
control. The amplified region of cDNA was probed with 
TaqMan fluorescence-labeled probe. TaqMan probe was 
very sensitive and is capable of detecting as few as 50 
copies of RNA/mL and as low as 5-10 molecules (Tsai et 
al. 2012). The specificity of primer and probe ensures that 
expression of the target DNA was specifically evaluated. 
Validation was performed in silico by using whole rat 
genome and in-vitro by using whole rat cDNA (Applied 
Biosystems, Foster, CA, USA). These were to ensure that 
specific sequences were detected. 
 The assay used (TaqMan®-catalog number: 
Rn00596601_m1 for Itgb3, Rn00580109_m1 for Cdh1 
and Rn01462585_m1 for Muc1 - Applied Biosystems, 
Foster City, CA, USA) amplifies 66 bp, 105 bp and 81 bp 
segments for Integrin αV/β3, Cdh1 and Muc1 respectively 
from the whole mRNA length of 787 bp (Itgb3), 4396 bp 
(Cdh1) and 2328 bp (Muc1). Gapdh (Rn99999916_s1) 
and Hprt1 (Rn01527840-m1) (Applied Biosystems, Foster 
City, CA, USA) were used as reference. 
 PCR program included 2 min at 50°C Uracil 
N-glycosylase (UNG), 20 s, 95°C activation of ampliTaq 
gold DNA polymerase and 1 min denaturation at 95°C, 20 
s and annealing/ extension at 60°C for 1 min. Denaturing 
and annealing were performed for 40 cycles. Negative 
controls were performed which include omission of reverse 
transcriptase (RT) or omission of cDNA. GenEx software 
(MultiD, Odingatan, Sweden) was used to normalized 
the measurements. This was followed by DataAssist v3 
software (Applied Biosystems, Foster City, CA, USA) 
that were used to calculate the RNA fold changes. Data 
were analyzed according to comparative CT (2^^DDCT) 
method. The relative quantity of target in each sample was 
determined by comparing the normalized target quantity 
to average normalized target quantity of references. 
STATISTICAL ANALYSIS
Student’s t-test and one-way analysis of variance (ANOVA) 
were used to determine the levels of significance. p < 0.05 
was considered as significant. Post-hoc statistical power 
analysis was performed and all values were >0.5 which 
indicate adequate sample size. 
RESULTS 
EFFECTS OF TESTOSTERONE ON αvβ3 INTEGRIN MRNA 
EXPRESSION AND ITS PROTEIN DISTRIBUTION IN UTERUS
Effects on αvβ3 integrin mRNA expression   Figure 1 
shows the expression level of αvβ3 integrin mRNA in rats 
A marked increase in αvβ3 integrin mRNA level was observed in rats received sex-steroid replacement without testosterone. 
Significant decrease in αvβ3 integrin mRNA level was observed in rats receiving testosterone treatment between days 6-8 
with or without flutamide or finasteride. *p<0.05 compared to normal steroid replacement. C: vehicle control, N: sex-steroid 
replacement, T: testosterone only treatment, T + FLU: testosterone and flutamide injection, T + FIN: testosterone and 
finasteride injection. Data was obtained from six different rats and was expressed as mean ± S.E.M.
FIGURE 1. αvβ3 integrin mRNA expression level in uterus
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receiving testosterone administered between days 6-8 of 
early pregnancy period. The highest mRNA levels were 
observed in non-testosterone treated rats received sex-
steroid replacement where the levels were approximately 
5.14 ± 0.15 fold significantly higher (p<0.05) as compared 
to ovariectomised control. Administration of testosterone 
between days 6 to 8 resulted in significant decreased 
(p<0.05) of αvβ3 integrin mRNA expression level in the 
uterus as compared to control. The effects of testosterone 
were neither antagonised by flutamide nor finasteride. 
Effects on αvβ3 integrin protein distribution   Figure 2 
shows αvβ3 integrin protein was highly distributed in the 
endometrium and myometrium of non-testosterone treated 
ovariectomised rats receiving sex-steroid replacement 
regime mimicking hormonal changes in early pregnancy. 
In rats receiving testosterone during the uterine receptivity 
period, distribution of this protein in different uterine 
compartments was remarkably reduced. Concomitant 
administration of either flutamide or finasteride had not 
inhibited the effect of testosterone on αvβ3 integrin 
distribution. 
EFFECTS OF TESTOSTERONE ON E-CADHERIN mRNA 
EXPRESSION AND ITS PROTEIN DISTRIBUTION IN UTERUS 
Effects on E-cadherin mRNA expression   Figure 3 shows 
level of E-cadherin mRNA was highest in non-testosterone 
treated ovariectomised rats which received sex-steroid 
replacement regime mimicking hormonal changes in 
early pregnancy. This level was approximately 1.98 ± 
0.15 fold significantly higher than ovariectomised control 
(p<0.05). Administration of testosterone between days 6 
and 8 resulted in significantly reduced (p<0.05) E-cadherin 
mRNA expression. Concomitant administration of either 
flutamide or finasteride with testosterone did not cause 
significant changes in E-cadherin mRNA expression level 
in the uterus.
Effect on E-cadherin protein distribution   Figure 4 
shows the distribution of E-cadherin where this protein 
could be seen to be distributed in the luminal epithelium, 
stroma, stromal and myometrial blood vessels. The 
highest distribution could be seen in non-testosterone 
treated ovariectomised rats receiving hormonal changes 
mimicking early pregnancy period. Administration of 
testosterone between days 6 and 8 causes expression 
of E-cadherin to markedly reduced. The effect of 
testosterone was not antagonised by either flutamide 
or finasteride as no marked changes in E-cadherin 
distribution was observed. 
EFFECTS OF TESTOSTERONE ON MUCIN-1 mRNA 
EXPRESSION AND ITS PROTEIN DISTRIBUTION IN UTERUS 
Effects on mucin-1 mRNA expression   Figure 5 
shows mucin-1 mRNA expression was highest in non-
testosterone treated rats receiving sex-steroid replacement 
mimicking hormonal changes in early pregnancy. The 
expression level was approximately 1.53 ± 0.14 fold 
Immunofluorescence images showing high distribution of αvβ3 integrin in the luminal epithelium of rats which received sex-steroid replacement 
without testosterone. αvβ3 integrin was markedly reduced following testosterone treatment between days 6-8. C: vehicle control, N: sex- steroid 
replacement regime, T: testosterone only treatment, T + FLU: testosterone and flutamide and T + FIN: testosterone and finasteride. NC: negative 
control. Arrows pointing towards αvβ3 integrin distribution. L = lumen. Scale bar = 50 μm. n=6 per treatment group
FIGURE 2. Distribution of αvβ3 integrin protein in uterus
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E-cadherin mRNA level was highest in rats receiving sex-steroid replacement without testosterone. E-cadherin mRNA 
levels were significantly decreased in rats receiving testosterone treatment with and without flutamide or finasteride. 
*p<0.05 compared to sex-steroid replacement. C: vehicle control, N: normal steroid replacement regime, T: testosterone 
only treatment, T + FLU: testosterone and flutamide injection and T + FIN: testosterone and finasteride injection. Data 
was obtained from six different rats and was expressed as mean ± S.E.M.
FIGURE 3. E-cadherin mRNA expression level in uterus
Immunofluorescence images showing high distribution of E-cadherin in luminal epithelium of rats which received sex-steroid replacement 
without testosterone. Distribution of E-cadherin was markedly reduced following testosterone treatment between days 6-8. C: vehicle control, 
N: sex-steroid replacement regime, T: testosterone only treatment, T + FLU: testosterone and flutamide and T + FIN: testosterone and 
finasteride. NC: negative control. Arrows pointing towards E-cadherin distribution. L = lumen. Scale bar = 50 μm. n=6 per treatment group
FIGURE 4. Distribution of E-cadherin protein in uterus
significantly higher than ovariectomised control (p<0.05). 
Administration of testosterone between days 6 and 8 
resulted in significant decrease in mucin-1 mRNA level 
(p<0.05). Testosterone effect was neither antagonised by 
flutamide nor finasteride. 
Effects on mucin-1 protein distribution   Figure 6 shows 
mucin-1 was distributed in endometrial luminal epithelium, 
stroma and stromal blood vessels and myometrium. 
The high distribution of mucin-1 was observed in non-
testosterone treated rats receiving sex-steroid replacement 
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mimicking the hormonal changes in early pregnancy. 
Mucin-1 expression was markedly reduced following 
testosterone treatment between days 6 and 8 of the sex-
steroid replacement. Concomitant administration of 
testosterone with either flutamide or finasteride did not 
result in any noticeable changes in mucin-1 distribution 
as compared to testosterone only treatment.
DISCUSSION
Blastocysts implantation occurs within a short window 
period known as uterine receptivity (Wang & Dey 
2006). During this period, the uterus undergoes series of 
transformation and becoming receptive to the implanting 
blastocyst. Uterine receptivity period can be identified 
based on the presence of receptivity markers such as 
αvβ3 integrin, E-cadherin and mucin-1. In this study, 
expression of mRNAs and proteins of these markers was 
markedly increased between days 6 to 8 of sex-steroid 
replacement, intended to mimic the hormonal changes 
in early pregnancy. Our findings have shown that during 
this period, administration of testosterone has resulted in 
marked decrease in the level of expression of these markers 
in the uterus. Furthermore, testosterone effects were found 
neither involved genomic pathway nor mediated via the 
active testosterone metabolites, DHT as evidence from 
The highest mucin-1 mRNA level was observed in rats receiving sex-steroid replacement without testosterone. Mucin-1 mRNA level 
was significantly decreased in rats receiving testosterone-only treatment with or without flutamide or finasteride. *p<0.05 compared to 
sex-steroid replacement. C: vehicle control, N: normal sex-steroid replacement, T: testosterone only treatment, T + FLU: testosterone 
and flutamide injection and T + FIN: testosterone and finasteride injection. Data were obtained from six different rats expressed as 
mean ± S.E.M.
FIGURE 5. Mucin-1 mRNA expression level in uterus
Immunofluorescence images showing distribution of mucin-1 which was highest in luminal epithelia of rats receiving sex-steroid replacement 
without testosterone. Low mucin-1 distribution was observed following testosterone treatment between days 6 - 8. C: vehicle control, N: sex-
steroid replacement, T: testosterone only treatment, T + FLU: testosterone and flutamide injection and T + FIN: testosterone and finasteride 
injection. NC: negative control. Arrows pointing towards mucin-1 distribution. L = lumen. Scale bar = 50 µm. n=6 per treatment group
FIGURE 6. Distribution of mucin-1 protein in uterus
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the effect observed following administration of either 
flutamide (an androgen receptor blocker) or finasteride (a 
5α-reductase inhibitor)
 The possibilities that testosterone effect on uterine 
receptivity could involve the non-genomic pathway are 
supported by the reported non-genomic action of this 
hormone on the uterine smooth muscles (Perusquía et al. 
1990). In addition, the non-genomic effect of testosterone 
on the uterus has also been shown by our previous 
findings in which this hormone down-regulates the 
expression of Cystic Fibrosis transmembrane regulator 
(CFTR) (Mohd Mokhtar et al. 2014), MECA-79 and 
pinopodes development during the uterine receptivity 
period in rats (Mokhtar et al. 2014). Absence or low level 
of 5α-reductase in the uterus might be the possible reason 
for the failure of testosterone to act on uterine cells via 
DHT. 
 αvβ3 integrin is one of the markers of uterine 
receptivity. This protein is involved in embryo recognition 
of the maternal endometrium (Reddy et al. 2001). 
Expression of αvβ3 integrin is markedly reduced in patient 
with infertility (Lessey 1998). Expression of αvβ3 integrin 
was found to be upregulated under the progesterone 
influence (Srinivasan et al. 2009). In this study, the up-
regulated expression of αvβ3 integrin in the uterus which 
occur following progesterone replacement suggested that 
this hormone likely responsible for the observed increase 
in αvβ3 integrin level. Its down-regulated expression 
following administration of testosterone could be due to 
counteraction of the progesterone effects, leading to failure 
of maternal recognition of embryo which subsequently 
impairs the establishment of pregnancy.
 Besides αvβ3 integrin, expression of E-cadherin in the 
uterus was also found to increase following progesterone 
replacement. This finding was consistent with a study 
which indicates that progesterone stimulates expression 
of E-cadherin in the uterus in mice (Jha et al. 2006). 
Expression of E-cadherin was also reported to increase 
at diestrus phase of the oestrous cycle, associated with 
high levels progesterone (Slater et al. 2002). The ability 
of testosterone to down-regulate expression of E-cadherin 
indicated that this hormone might impair embryo-
uterus communication that is crucial for the successful 
establishment of pregnancy (Liu et al. 2006). 
 Expression of mucin-1 in the uterus during receptivity 
period is important as it forms scaffold that allows 
blastocyst to roll over the surface epithelium, thus 
preventing the embryo from sticking to the site other 
than that destined for implantation (Giudice 1999). The 
highest expression of mucin-1 was observed following 
progesterone replacement, consistent with the observation 
in humans in which mucin-1 was found to be highly 
expressed under the influence of progesterone (Aplin 
et al. 1998). Additionally, expression of mucin-1 which 
was highest at the apical membrane of uterine luminal 
epithelium supports its role in preventing blastocyst-
endometrial adhesion (Horne et al. 2002). Down-regulation 
of mucin-1 by testosterone could result in premature 
adhesion of the embryo to the endometrium, which could 
halt the attachment and invasion.
CONCLUSION
In conclusions, decreased expression and distribution of 
αvβ3 integrin, E-cadherin and mucin-1 in uterus during 
receptivity period would impair successful embryo 
implantation and pregnancy establishment. This might 
contribute to infertility in women having high plasma 
testosterone in disease such as Polycystic Ovarian Disease 
or following excessive anabolic steroid intake. 
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